OpenVSafe by OpenVAERS
Search V-safe

QXL-10074-93281

2 vaccinations 2 coded responses 23 check-ins 2 free-text entries 1 call case
Sex
Female
Age at first dose
26-30
ZIP prefix
015 / MA
Registered
2021-03-25
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-25
    Registered in v-safe
  2. 2021-03-25
    Dose 1 — Pfizer-BioNTech
  3. 2021-03-25
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-03-26
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Fever · Headache, Fatigue or tiredness
    Adult check-in
  5. 2021-03-27
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Headache
    Adult check-in
  6. 2021-03-28
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Headache · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  7. 2021-03-29
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Headache
    Adult check-in
  8. 2021-03-30
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Headache
    Adult check-in
  9. 2021-04-01
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-04-08
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-04-15
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-04-17
    Dose 2 — Pfizer-BioNTech
  13. 2021-04-18
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  14. 2021-04-19
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  15. 2021-04-21
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Headache
    Adult check-in
  16. 2021-04-22
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Headache
    Adult check-in
  17. 2021-04-23
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Headache
    Adult check-in
  18. 2021-04-24
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-05-01
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-05-08
    Survey response — day 21, dose 2
    MedDRA: Emergency care, Palpitations — Feeling: Good
    Free text: Heart palpitations. Visited the ER, diagnosed with PVC.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  21. 2021-05-15
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-05-22
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-05-29
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-07-17
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-10-16
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  26. 2022-04-17
    Survey response — 12 months, dose 2
    MedDRA: Pre-eclampsia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, Hospitalization
    Free text: Pregnancy Preeclampsia
    MedDRA releases: 2024-11 · check-in free text available
  27. 2022-04-17
    Report sent to call center — 12 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
  28. 2022-04-21
    Call successful
    Not applicable - Accidental Reporting

Vaccinations

DoseDateManufacturerCo-administered
12021-03-25Pfizer-BioNTech
22021-04-17Pfizer-BioNTech

Call center

1 call center case

1 successful

See the call center timeline

Free text

Release 8 — day 21, dose 2

2021-05-08

Symptoms: Heart palpitations. Visited the ER, diagnosed with PVC.

Release 11 — 12 months, dose 2

2022-04-17

Symptoms: Pregnancy Preeclampsia

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDEmergency care ✓ ✓ ✓
SDPalpitations ✓ ✓ ✓
SDPre-eclampsia · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…